ALDEYRA THERAPEUTICS INC (ALDX)
US01438T1060 - Common Stock
ALDEYRA THERAPEUTICS INC
NASDAQ:ALDX (9/27/2023, 7:11:09 PM)
After market: 6.11 0 (0%)6.11
-0.04 (-0.65%)
Company Profile
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. The company is headquartered in Lexington, Massachusetts and currently employs 15 full-time employees. The company went IPO on 2014-05-02. The firm's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the treatment of primary vitreoretinal lymphoma, proliferative vitreoretinopathy, and other rare sight-threatening retinal diseases. Its ADX-629, is an orally administered RASP modulator in clinical development for atopic dermatitis, idiopathic nephrotic syndrome, moderate alcohol-associated hepatitis, chronic cough, and Sjogren-Larsson Syndrome. Its ADX-246 and ADX-248, for geographic atrophy and systemic inflammatory diseases.
Company Info
ALDEYRA THERAPEUTICS INC
131 Hartwell Avenue, Suite 320
Lexington MASSACHUSETTS 02421
P: 17817614904.0
CEO: Todd C. Brady
Employees: 15
Website: https://www.aldeyra.com/
ALDX News
4 hours ago - Bragar Eagel & Squire, P.C.ALDEYRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Aldeyra Therapeutics, Inc. and Encourages Investors to Contact the Firm
a day ago - Bronstein, Gewirtz & Grossman, LLCFinal Deadline Alert: ALDX Investor Alert: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Aldeyra Therapeutics, Inc. Class Action Lawsuit/PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has...
2 days ago - Bronstein, Gewirtz & Grossman, LLCDeadline Alert: ALDX Investor Alert: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Aldeyra Therapeutics, Inc. Class Action LawsuitSan Diego, CA -- (SBWIRE) -- 09/25/2023 -- The Shareholders Foundation announced that a deadline is coming up on September 29, 2023 in the lawsuit filed for certain investors of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX).
3 days ago - The Rosen Law Firm PAALDX DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action – ALDX
4 days ago - THE ROSEN LAW FIRM, P. A.ALDX FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action - ALDX/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between...
ALDX Twits
Here you can normally see the latest stock twits on ALDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
